Evidence map›Paper›PMID 26977398›Full record

ArticleNeuroImage. Clinical2016

Patterns of regional cerebellar atrophy in genetic frontotemporal dementia.

Martina Bocchetta, M Jorge Cardoso, David M Cash, Sebastien Ourselin, Jason D Warren, Jonathan D Rohrer

Open access · goldAbstract read
In one paragraph

Article in NeuroImage. Clinical, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Longitudinal imaging inNeuroImage. Clinical · 2016
    Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Cerebellar Regional Dissection for Molecular Analysis.Journal of visualized experiments : JoVE · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Martina BocchettaDementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.
M Jorge CardosoDementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK; Translational Imaging Group, Centre for Medical Image Computing (CMIC), University College London, UK.
David M CashDementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK; Translational Imaging Group, Centre for Medical Image Computing (CMIC), University College London, UK.
Sebastien OurselinTranslational Imaging Group, Centre for Medical Image Computing (CMIC), University College London, UK.
Jason D WarrenDementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.
Jonathan D RohrerDementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK. Electronic address: j.rohrer@ucl.ac.uk.
University College London · GBNational Hospital for Neurology and Neurosurgery · GBUK Dementia Research Institute · GB

Funding

Medical Research Council MR/J01107X/1Medical Research Council MR/M008525/1Medical Research Council MR/M023664/1Wellcome Trust 091673/Z/10/Z
6 · The paper itself

Abstract

backgroundFrontotemporal dementia (FTD) is a heterogeneous neurodegenerative disorder with a strong genetic component. The cerebellum has not traditionally been felt to be involved in FTD but recent research has suggested a potential role.

methodsWe investigated the volumetry of the cerebellum and its subregions in a cohort of 44 patients with genetic FTD (20 MAPT, 7 GRN, and 17 C9orf72 mutation carriers) compared with 18 cognitively normal controls. All groups were matched for age and gender. On volumetric T1-weighted magnetic resonance brain images we used an atlas propagation and label fusion strategy of the Diedrichsen cerebellar atlas to automatically extract subregions including the cerebellar lobules, the vermis and the deep nuclei.

resultsThe global cerebellar volume was significantly smaller in C9orf72 carriers (mean (SD): 99989 (8939) mm(3)) compared with controls (108136 (7407) mm(3)). However, no significant differences were seen in the MAPT and GRN carriers compared with controls (104191 (6491) mm(3) and 107883 (6205) mm(3) respectively). Investigating the individual subregions, C9orf72 carriers had a significantly lower volume than controls in lobule VIIa-Crus I (15% smaller, p < 0.0005), whilst MAPT mutation carriers had a significantly lower vermal volume (10% smaller, p = 0.001) than controls. All cerebellar subregion volumes were preserved in GRN carriers compared with controls.

conclusionThere appears to be a differential pattern of cerebellar atrophy in the major genetic forms of FTD, being relatively spared in GRN, localized to the lobule VIIa-Crus I in the superior-posterior region of the cerebellum in C9orf72, the area connected via the thalamus to the prefrontal cortex and involved in cognitive function, and localized to the vermis in MAPT, the 'limbic cerebellum' involved in emotional processing.

Indexed as

AdultAgedAtrophyC9orf72 ProteinCase-Control StudiesCerebellumFemaleFrontotemporal DementiaHumansImage Processing, Computer-AssistedIntercellular Signaling Peptides and ProteinsMagnetic Resonance ImagingMaleMiddle AgedMutationProgranulinsC9orf72 ProteinC9orf72 protein, humanGRN protein, humanIntercellular Signaling Peptides and ProteinsMAPT protein, humanProgranulinsProteinstau ProteinsC9orf72CerebellumGenetic frontotemporal dementia

Identifiers

PMID26977398
PMCPMC4781923
OpenAlexW2282191832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.